Hologic to acquire medical aesthetic laser company Cynosure

Women's healthcare and diagnostics company Hologic (Marlborough, MA) and medical aesthetic laser maker Cynosure (Westford, MA) have signed a definitive agreement in which Hologic will acquire all outstanding Cynosure shares for $66 per share in cash, which corresponds to an equity value of approximately $1.65 billion and an enterprise value of $1.44 billion net of cash.

The transaction, which has been approved unanimously by the boards of directors of both companies, would extend Hologic's scientific and commercial capabilities, while expanding Cynosure's customer reach and addressable market.

Cynosure's aesthetic laser product portfolio includes systems for noninvasive body contouring, hair removal, skin revitalization, and women's health. The company's most recent product introductions are its SculpSure laser treatment for noninvasive body contouring, which was cleared by the FDA in 2015, and its MonaLisa Touch CO₂ laser for women's health. The company, which reported revenues of $433.5 million in 2016, has posted 28 consecutive quarters of year-over-year top-line growth.

The deal is expected to be completed in late March or April 2017.

For more information, please visit www.hologic.com and www.cynosure.com.